26 October 2021: Clinical Research
Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis
Darius Gleiznys 1ABCDEFG* , Albertas Kriauciunas 1BCDE , Julius Maminskas 1AB , Arturas Stumbras 2FG , Dalia Giedrimiene 3CD , Christine Niekrash 4CDE , Alvydas Gleiznys 1AD , Jurgina Sakalauskiene 1ABEF , Astra Vitkauskiene 5ACDEDOI: 10.12659/MSM.932243
Med Sci Monit 2021; 27:e932243
Table 2 Significance of differences in probing depth, plaque index, and marginal bleeding index of healthy subjects, and the mucositis patients untreated and treated groups.
| Study groups | Probing depth, mm | Plaque index | Marginal bleeding index |
|---|---|---|---|
| Median [25–75%] | |||
| HP, n=30 | 1.4 [1.2–1.6] | 0 | 0 |
| MP, n=30 | 3.0 [2.8–3.2] | 0.6 [0.3–0.8] | 0.28 [0.27–0.29] |
| TP, n=30 | 2.95 [2.8–3.1] | 0.1 [0.06–0.11] | 0.03 [0–0.09] |
| χ=61,071, df=2, P | χ=57.95, df=2, P | χ=65.045, df=2, P | |
| χ – by Kruskal-Wallis test, multiple comparison by Mann-Whitney test; df – degrees of freedom; HP – healthy subjects; MP – patients with untreated peri-implant mucositis; TP – patients treated with mechanical anti-infective therapies for mucositis. | |||